Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren E Hendy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Lipidology|January 24, 2025
Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payersLauren E Hendy, Lisa P Spees, Casey Tak, et al.
Addiction Science & Clinical Practice|February 12, 2025
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorderMarlene C Lira, Lauren E Hendy, Alisha Liakas, et al.
Atherosclerosis|April 27, 2024
An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patientsLauren E Hendy, Lisa P Spees, Casey Tak, et al.
JAMA Network Open|August 18, 2025
Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction TreatmentLauren E Hendy, Lucas G Hill, Amanda Olguin, et al.
Journal of Patient Experience|July 28, 2025
Virtual Backgrounds, Clinician Attire, and Patient Experience Preferences Among Individuals Receiving Telemedicine Treatment for Opioid Use DisorderMarlene C Lira, Lauren E Hendy, Amanda Olguin, et al.
Journal of Addiction Medicine|February 9, 2026
Treating Hepatitis C Within Real-world Telemedicine Addiction CareMarlene C Lira, Lauren E Hendy, Judith I Tsui, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Lipidology|January 24, 2025
Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payersLauren E Hendy, Lisa P Spees, Casey Tak, et al.
Addiction Science & Clinical Practice|February 12, 2025
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorderMarlene C Lira, Lauren E Hendy, Alisha Liakas, et al.
Atherosclerosis|April 27, 2024
An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patientsLauren E Hendy, Lisa P Spees, Casey Tak, et al.
JAMA Network Open|August 18, 2025
Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction TreatmentLauren E Hendy, Lucas G Hill, Amanda Olguin, et al.
Journal of Patient Experience|July 28, 2025
Virtual Backgrounds, Clinician Attire, and Patient Experience Preferences Among Individuals Receiving Telemedicine Treatment for Opioid Use DisorderMarlene C Lira, Lauren E Hendy, Amanda Olguin, et al.
Journal of Addiction Medicine|February 9, 2026
Treating Hepatitis C Within Real-world Telemedicine Addiction CareMarlene C Lira, Lauren E Hendy, Judith I Tsui, et al.
Pageof 1